Hepatocyte transplantation for treatment of liver failure and inherited metabolic diseases

The study aims to examine the ability of transplanted hepatocytes to treat inherited metabolic diseases (e.g., Crigler-Najjar Disease, familial hypercholesterolemia, urea cycle disorders) or liver failure, in patients who are unlikely to survive without extensive medical therapy or transplantation.